The latest in features and updates that are relevant to sickle cell research, from publications around the world.
08 Jul 2021
CTX001 is being investigated in two ongoing Phase 1/2 clinical trials as a potential one-time therapy for patients suffering from transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD). In total, more than 40 patients have been dosed across both studies to date. All 15 patients with TDT, including six who have the beta […]Learn more
06 Jul 2021
Patients with sickle cell disease (SCD) have vaso-occlusive crises (VOCs). Infusion centers (ICs) are alternatives to emergency department (ED) care and may improve patient outcomes.Learn more
23 Jun 2021
The American Red Cross says we are in the midst of a severe blood donation shortage. “People with sickle cell disease depend on blood transfusions regularly.”Learn more